Camp4 Therapeutics Corp SEC filings CAMP

Camp4 Therapeutics Corp has 192 filings in SEC EDGAR's recent list, going back to Sep 25, 2018. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026. The company's fiscal year ends on December 31.

Form Description Filed Period
424B3 Prospectus Aug 12, 2026 —
S-3 Shelf registration Aug 6, 2026 —
S-8 Employee stock plan registration Mar 5, 2026 —
424B5 Prospectus supplement Dec 18, 2025 —
FWP Free writing prospectus Dec 18, 2025 —
424B5 Prospectus supplement Dec 1, 2025 —
424B3 Prospectus Nov 25, 2025 —
S-3 Shelf registration Nov 10, 2025 —
S-3 Shelf registration Nov 3, 2025 —
S-8 Employee stock plan registration Mar 27, 2025 —
S-8 Employee stock plan registration Oct 16, 2024 —
424B4 Prospectus Oct 11, 2024 —
S-1/A Amended registration statement Oct 7, 2024 —
S-1/A Amended registration statement Sep 26, 2024 —
S-1 Registration statement Sep 20, 2024 —

Showing 15 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
CAMP (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Watertown, MA
SEC filer status
, Emerging growth company
SEC CIK
1736730

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.